The field of interventional cardiology and interventional vascular medicine now comprises the dominant diagnostic and therapeutic field within cardiovascular medicine, and continues to grow in terms of patients managed and physicians trained. The Textbook of Cardiovascular Intervention is intended to provide a modern, comprehensive and practical text on interventional cardiology for the current, rapidly evolving practice environment. It is written by a group of worldwide experts in the field and will appeal to fellows, residents and physicians in cardiology, interventional cardiology, cardiothoracic and vascular surgery, vascular and endovascular medicine, neurointerventional radiology and surgery, emergency medicine and intensive care.  

Dr. Craig A. Thompson is a world leader in interventional cardiology and in the field of complex cardiovascular interventions, including therapies for chronic total occlusive vascular diseases. He has performed thousands of cardiac and vascular interventions, and chronic total occlusion percutaneous coronary intervention's (CTO PCI's) in the cardiac and peripheral vessels. In partnership with many colleagues throughout the United States and globally, Dr. Thompson has assembled the first and largest experience in the United States for retrograde techniques and other innovative techniques and technologies for chronic total occlusion. The Yale CTO PCI program is among the most active and innovative in the world for management of occlusive coronary diseases. Dr. Thompson has actively participated or led many efforts for innovative technique refinement and technology development for CTO PCI.Dr. Craig A. Thompson previously served as Director of Cardiovascular Catheterization and Intervention with Yale New Haven Hospital and Director of Invasive Cardiology and Vascular Medicine with Yale University School of Medicine in New Haven, CT. He is now senior vice president and chief medical officer, Interventional Cardiology, at Boston Scientific responsible for driving the development of innovative medical solutions within the Boston Scientific Interventional Cardiology business.